Franziska Jahn

834 total citations
21 papers, 528 citations indexed

About

Franziska Jahn is a scholar working on Surgery, Oncology and Physiology. According to data from OpenAlex, Franziska Jahn has authored 21 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 8 papers in Oncology and 6 papers in Physiology. Recurrent topics in Franziska Jahn's work include Nausea and vomiting management (11 papers), Anesthesia and Pain Management (10 papers) and Cancer Treatment and Pharmacology (5 papers). Franziska Jahn is often cited by papers focused on Nausea and vomiting management (11 papers), Anesthesia and Pain Management (10 papers) and Cancer Treatment and Pharmacology (5 papers). Franziska Jahn collaborates with scholars based in Germany, United States and Switzerland. Franziska Jahn's co-authors include Matti Aapro, Karin Jordan, Karin Jordan, Berit Jordan, Carsten Müller‐Tidow, Petra Feyer, Hans‐Joachim Schmoll, Daniele Santini, V. Sibaud and Peter Arne Gerber and has published in prestigious journals such as Cochrane Database of Systematic Reviews, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Franziska Jahn

20 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franziska Jahn Germany 13 283 180 154 82 73 21 528
David D. Biggs United States 10 238 0.8× 231 1.3× 137 0.9× 33 0.4× 71 1.0× 20 570
John D. Hainsworth United States 8 372 1.3× 295 1.6× 178 1.2× 46 0.6× 61 0.8× 11 677
Veerabhadram Garimella United Kingdom 10 408 1.4× 132 0.7× 40 0.3× 28 0.3× 52 0.7× 16 689
Madhuri Bajaj United States 7 253 0.9× 215 1.2× 142 0.9× 13 0.2× 47 0.6× 12 539
Aura Erazo France 3 161 0.6× 173 1.0× 67 0.4× 25 0.3× 39 0.5× 5 377
C. Basurto Italy 10 266 0.9× 120 0.7× 64 0.4× 17 0.2× 28 0.4× 13 465
Carlos Carracedo Peru 7 178 0.6× 250 1.4× 77 0.5× 23 0.3× 133 1.8× 13 554
James Gilmore United States 10 214 0.8× 51 0.3× 113 0.7× 12 0.1× 42 0.6× 30 361
Jeong-Eun Kim South Korea 12 106 0.4× 161 0.9× 41 0.3× 24 0.3× 215 2.9× 22 568
J Hidding Netherlands 6 184 0.7× 315 1.8× 53 0.3× 17 0.2× 20 0.3× 10 410

Countries citing papers authored by Franziska Jahn

Since Specialization
Citations

This map shows the geographic impact of Franziska Jahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franziska Jahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franziska Jahn more than expected).

Fields of papers citing papers by Franziska Jahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franziska Jahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franziska Jahn. The network helps show where Franziska Jahn may publish in the future.

Co-authorship network of co-authors of Franziska Jahn

This figure shows the co-authorship network connecting the top 25 collaborators of Franziska Jahn. A scholar is included among the top collaborators of Franziska Jahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franziska Jahn. Franziska Jahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jordan, Berit, Franziska Jahn, & Karin Jordan. (2025). Peripheral neuropathy: from guidelines to clinical practise. Current Opinion in Oncology. 37(2). 168–174.
2.
Jordan, Karin, Alexandre Chan, Richard J. Gralla, et al.. (2023). Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents—updated MASCC/ESMO consensus recommendation. Supportive Care in Cancer. 32(1). 53–53. 12 indexed citations
3.
Jahn, Franziska, et al.. (2022). The prevention and treatment of nausea and vomiting during tumor therapy. Deutsches Ärzteblatt international. 119(21). 382–392. 6 indexed citations
4.
Lacouture, Mario E., V. Sibaud, Peter Arne Gerber, et al.. (2020). Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆. Annals of Oncology. 32(2). 157–170. 74 indexed citations
5.
Jordan, Berit, Franziska Jahn, Sandra Sauer, & Karin Jordan. (2019). Prevention and Management of Chemotherapy-Induced Polyneuropathy. Breast Care. 14(2). 79–84. 32 indexed citations
6.
Jordan, Karin, et al.. (2017). Is the addition of a neurokinin-1 receptor antagonist beneficial in moderately emetogenic chemotherapy?—a systematic review and meta-analysis. Supportive Care in Cancer. 26(1). 21–32. 21 indexed citations
7.
Jordan, Berit, et al.. (2016). Calcium and Magnesium Infusions for the Prevention of Oxaliplatin-Induced Peripheral Neurotoxicity: A Systematic Review. Oncology. 90(6). 299–306. 30 indexed citations
8.
Jordan, Karin, Alexandre Chan, Richard J. Gralla, et al.. (2016). 2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents. Supportive Care in Cancer. 25(1). 271–275. 33 indexed citations
9.
Jordan, Karin, et al.. (2016). Diagnostic work-up for the detection of malnutrition in hospitalized cancer patients. The Journal of Community and Supportive Oncology. 14(4). 155–161. 4 indexed citations
10.
Feyer, Petra, Franziska Jahn, & Karin Jordan. (2015). Prophylactic Management of Radiation-Induced Nausea and Vomiting. BioMed Research International. 2015. 1–8. 20 indexed citations
11.
Jahn, Franziska, et al.. (2015). Addition of the Neurokinin-1-Receptor Antagonist (RA) Aprepitant to a 5-Hydroxytryptamine-RA and Dexamethasone in the Prophylaxis of Nausea and Vomiting Due to Radiation Therapy With Concomitant Cisplatin. International Journal of Radiation Oncology*Biology*Physics. 92(5). 1101–1107. 9 indexed citations
12.
Jordan, Karin, Franziska Jahn, Berit Jordan, et al.. (2015). Trabectedin: Supportive care strategies and safety profile. Critical Reviews in Oncology/Hematology. 94(3). 279–290. 10 indexed citations
13.
Jahn, Franziska, et al.. (2015). Safety and Efficacy of Liposomal Cytarabine in the Treatment of Neoplastic Meningitis. Oncology. 89(3). 137–142. 15 indexed citations
14.
Jahn, Franziska, et al.. (2015). Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review. Annals of Oncology. 26(6). 1081–1090. 127 indexed citations
15.
Jordan, Karin, et al.. (2014). Neuropharmacology and Management of Chemotherapy-Induced Nausea and Vomiting in Patients with Breast Cancer. Breast Care. 9(4). 246–253. 11 indexed citations
16.
Feyer, Petra, Franziska Jahn, & Karin Jordan. (2013). Radiation induced nausea and vomiting. European Journal of Pharmacology. 722. 165–171. 32 indexed citations
17.
Bernig, Toralf, et al.. (2013). Treatment of Adolescents and Young Adults (AYA) with Cancer in a Multidisciplinary Setting: On the Way to a Highly Specialized AYA Unit. Klinische Pädiatrie. 225(6). 335–338. 7 indexed citations
18.
Aapro, Matti, Hans‐Joachim Schmoll, Franziska Jahn, Alexandra D. Carides, & R. Timothy Webb. (2012). Review of the efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in a range of tumor types. Cancer Treatment Reviews. 39(1). 113–117. 23 indexed citations
20.
Jahn, Franziska, et al.. (1963). Relative activity of fasciolicidal agents in the 'liver fluke-implantation-test'.. Wiener Tierarztliche Monatsschrift. 50(2). 213–217. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026